
Opinion|Videos|September 25, 2024 (Updated: September 25, 2024)
Advancing MDD Treatment: From STAR*D Insights to Precision Medicine and Novel Therapeutics
Experts in the management of mood disorders comment on the evolving management of major depressive disorder, emphasizing findings from the STAR*D trial, updated treatment guidelines, and the role of precision medicine and the shift toward personalized, rapid-acting treatments to improve patient outcomes.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Postmodern Worldview and Contemporary Psychiatry
2
New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial: The Power of Another COMP360 Dose
3
DT120 (Lysergide) ODT Receives Breakthrough Therapy Designation for Treatment of MDD
4
New Phase 3 Data on Oveporexton for Narcolepsy Type 1
5








